Funder
Japanese Ministry of Education, Culture, Sports, Science, and Technology
Japan Intractable Diseases Research Foundation
Japan Agency for Medical Research and Development, Practical Research Project for Rare/Intractable Diseases
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference34 articles.
1. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795–809.
2. Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63:26–33.
3. Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990;343:364–6.
4. Athanasiou D, Aguila M, Bellingham J, Li W, McCulley C, Reeves PJ, et al. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy. Prog Retin Eye Res. 2018;62:1–23.
5. Farrar GJ, Kenna P, Redmond R, McWilliam P, Bradley DG, Humphries MM, et al. Autosomal dominant retinitis pigmentosa: absence of the rhodopsin proline––histidine substitution (codon 23) in pedigrees from Europe. Am J Hum Genet. 1990;47:941–5.